Ally Bridge Group’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-32,057
Closed -$3.59M 28
2024
Q1
$3.59M Buy
+32,057
New +$3.59M 2% 19
2023
Q2
Sell
-47,651
Closed -$4.9M 20
2023
Q1
$4.9M Hold
47,651
6.42% 8
2022
Q4
$6.98M Buy
47,651
+10,389
+28% +$1.52M 6.79% 4
2022
Q3
$6.3M Buy
+37,262
New +$6.3M 4.16% 10